Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L FELDMAN

Showing results (1421-1430 of 1,491) with videos related to

Pageof 150
Sort By:
Journal of the American College of Cardiology|February 14, 2015
A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesionsPhilippe Généreux, Indulis Kumsars, Maciej Lesiak, et al.
JACC. Cardiovascular Interventions|May 24, 2014
Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II)Jeffrey W Chambers, Robert L Feldman, Stevan I Himmelstein, et al.
Hematological Oncology|October 7, 2025
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) CohortJames R Cerhan, Tereza Sokolova, Elliott J Cahn, et al.
Kidney International|August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working GroupCarla M Nester, David L Feldman, Richard Burwick, et al.
Bioorganic & Medicinal Chemistry|January 14, 2025
Modeling, synthesis and cell-based evaluation of pyridine-substituted analogs of CD3254 and fluorinated analogs of CBt-PMN as novel therapeuticsPeter W Jurutka, Zainab Khan, Ichiro Kaneko, et al.
Blood|May 31, 2022
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOSTyler A Herek, Alyssa Bouska, Waseem Lone, et al.
The Lancet. Oncology|February 25, 2018
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohortsSarah Huet, Bruno Tesson, Jean-Philippe Jais, et al.
American Journal of Hematology|July 29, 2016
Early event status informs subsequent outcome in newly diagnosed follicular lymphomaMatthew J Maurer, Emmanuel Bachy, Hervé Ghesquières, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell LymphomaWaseem Lone, Alyssa Bouska, Sunandini Sharma, et al.
Haematologica|May 6, 2021
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphomaJoan Enric Ramis-Zaldivar, Blanca Gonzalez-Farre, Alina Nicolae, et al.
Pageof 150

Showing results (1421-1430 of 1,491) with videos related to

Sort By:
Pageof 150
Journal of the American College of Cardiology|February 14, 2015
A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesionsPhilippe Généreux, Indulis Kumsars, Maciej Lesiak, et al.
JACC. Cardiovascular Interventions|May 24, 2014
Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II)Jeffrey W Chambers, Robert L Feldman, Stevan I Himmelstein, et al.
Hematological Oncology|October 7, 2025
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) CohortJames R Cerhan, Tereza Sokolova, Elliott J Cahn, et al.
Kidney International|August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working GroupCarla M Nester, David L Feldman, Richard Burwick, et al.
Bioorganic & Medicinal Chemistry|January 14, 2025
Modeling, synthesis and cell-based evaluation of pyridine-substituted analogs of CD3254 and fluorinated analogs of CBt-PMN as novel therapeuticsPeter W Jurutka, Zainab Khan, Ichiro Kaneko, et al.
Blood|May 31, 2022
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOSTyler A Herek, Alyssa Bouska, Waseem Lone, et al.
The Lancet. Oncology|February 25, 2018
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohortsSarah Huet, Bruno Tesson, Jean-Philippe Jais, et al.
American Journal of Hematology|July 29, 2016
Early event status informs subsequent outcome in newly diagnosed follicular lymphomaMatthew J Maurer, Emmanuel Bachy, Hervé Ghesquières, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell LymphomaWaseem Lone, Alyssa Bouska, Sunandini Sharma, et al.
Haematologica|May 6, 2021
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphomaJoan Enric Ramis-Zaldivar, Blanca Gonzalez-Farre, Alina Nicolae, et al.
Pageof 150